Cross-fund · 5 holders
RLMD
RELMADA THERAPEUTICS INC
CUSIP 75955J402
5
Tracked holders
$45.7M
Aggregate value
6,929,242
Shares
5
Active funds
Funds holding RLMD
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| Millennium | Multi-Strategy | Q1 2026 | $27.2M | 0.01% | +2,234,248 | +133.5% |
| BlackRock | Institutional | Q1 2026 | $9.0M | — | +22,047 | +1.7% |
| Vanguard | Institutional | Q4 2025 | $5.8M | — | +784,727 | +187.5% |
| Point72FEAT | Multi-Strategy | Q1 2026 | $3.5M | — | +317,443 | +169.4% |
| Citadel | Multi-Strategy | Q1 2026 | $169,128 | — | -50,563 | -67.5% |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.